发明名称 |
ANTICANCER FUSION PROTEIN |
摘要 |
<p>A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid hTRAIL281; and at least one domain (b) which is a sequence of a cytolytic effector peptide forming pores in the cell membrane, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases.</p> |
申请公布号 |
SG11201403282Q(A) |
申请公布日期 |
2014.07.30 |
申请号 |
SG11201403282Q |
申请日期 |
2012.12.22 |
申请人 |
ADAMED SP. Z O.O. |
发明人 |
PIECZYKOLAN, JERZY SZCZEPAN;PAWLAK, SEBASTIAN DOMINIK;ZEREK, BARTLOMIEJ MACIEJ;RÓZGA, PIOTR KAMIL |
分类号 |
C07K14/705;A61K38/17;A61P35/00;C12N15/12;C12N15/62 |
主分类号 |
C07K14/705 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|